Canada markets closed

Sigyn Therapeutics, Inc. (SIGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.250.00 (0.00%)
At close: 01:41PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
0
0
0
0
0
Operating Expenses
Research Development
767.055
798.165
657.657
734.014
419.362
Selling General and Administrative
1,500
1,657
1,490
1,274
497.072
Total Operating Expenses
2,267
2,455
2,147
2,008
916.434
Operating Income or Loss
-2,267
-2,455
-2,147
-2,008
-916.434
Interest Expense
392.914
2,044
782.552
460.355
343.156
Total Other Income/Expenses Net
352.965
352.965
-
-536.047
-
Income Before Tax
-3,298
-4,146
-2,930
-3,005
-1,260
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-3,298
-4,146
-2,930
-3,005
-1,260
Net Income
-3,298
-4,146
-2,930
-3,005
-1,260
Net Income available to common shareholders
-3,298
-4,146
-2,930
-3,005
-1,260
Basic EPS
-0.09
-
-3.13
-3.20
-6.80
Diluted EPS
-0.09
-
-3.13
-3.20
-6.80
Basic Average Shares
40,948
-
934.915
909.914
183.781
Diluted Average Shares
40,948
-
934.915
909.914
183.781